Myths About Treatment & Injectables

Obesity is a long-term, chronic condition — yet it’s often misunderstood. In recent years, new medications, including injectable treatments for obesity, have changed how doctors manage weight. But misconceptions still keep many people from getting the help they need.

Let’s look at a few common myths, and what research really shows.

Myth 1: Obesity treatment is only about diet and exercise

Fact: While nutrition and activity are essential, many people need more support because biology also plays a key role. Evidence shows that medications that target gut hormones can help regulate appetite and improve metabolism when combined with lifestyle changes.

Myth 2: Injectables are only for serious illnesses

Fact: The injectable route isn’t limited to severe diseases. In recent years, many safe and effective medications for chronic conditions, including obesity, are available as injectables. They’re designed for convenience and consistent results, not because the condition is “serious.” When prescribed and monitored by a doctor, these medications are well-tolerated and suitable for long-term use.

Myth 3: Once you stop treatment, all the weight comes back

Fact: Stopping medication may lead to some weight regain, but healthy habits developed along the way can help maintain progress. Research suggests that continued medical follow-up and lifestyle changes can lead to better long-term outcomes. That said, since obesity is a long-term and chronic condition, it is not recommended to stop your treatment without having a conversation with your doctor.

Myth 4: These medicines are only for people with diabetes

Fact: Several injectables are approved specifically for chronic weight management, even in people without diabetes. They work on the same gut hormones involved in hunger and fullness.

Modern obesity treatment is about combining science, behavior, and medical guidance, not just willpower. Busting the myths and understanding the facts can help people make informed, confident choices about their health.

Related Articles

Disclaimers: This initiative is solely for patient support. It has been created with an intention to provide, assistance and support to patients & NOT intended towards product promotion, NOR advertisement of any health care professionals or doctors.  Patients should be advised to consult and seek medical advice from their concerned doctor/ health care professional before starting any treatment/medicine/ diet plan. Any advice regarding the management of any medical condition is completely at the discretion of their consulting physician/doctor (Registered Medical Practitioner). Cipla limited makes no representations as to the efficacy, accuracy, appropriateness, or suitability of any specific tests, products, procedures, treatments, services, opinions, healthcare providers or other information that may be shared through this screening/program/activity. Cipla shall not be responsible for any direct, indirect, consequential or other damages arising therefrom. No personal data is being collected, stored, or processed by Cipla as a part of this initiative. Yurpeak®, KwikPen® and Lilly are registered trademark of Eli Lilly & Company, promoted and distributed by Cipla in India. The “CIPLA” mark and logo are the sole and intellectual property of Cipla Limited. Nothing on this website should be construed as giving medical advice or making recommendations regarding any health-related decision or action. You should consult a doctor or other qualified healthcare professional regarding any questions about your health or before making any treatment-related decisions. The contents of this site are not intended to substitute the medical judgment of your treating physicians. This website is intended for people over 18 years of age. This website is intended for the sole use of registered health care providers and patients prescribed with Yurpeak (tirzepatide) on their physician's advice. Yurpeak and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. Yurpeak is available by prescription only. To be sold by retail under prescription of Endocrinologist or Internal Medicine specialists only. For adverse events and safety reporting, please reach out to: drugsafety@cipla.com or report to Cipla Ltd. on 18002577779 For any additional information related to Lilly products, please reach out to: queries_in-medinfo@lilly.com.